We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant
ARTLW

Delisted

ARTLW was delisted on the 17th of June, 2024.

Back to rankings

5 hedge funds and large institutions have $748 invested in Artelo Biosciences, Inc. Warrant in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding

Funds holding: 3 → 5 (+2)

55% less capital invested

Capital invested by funds: $1.66K → $748 (-$916)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$100
2
Bank of America
Bank of America
North Carolina
+$6

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$440 – – –
AGM
2
Alpine Global Management
New York
$226 – – –
UBS Group
3
UBS Group
Switzerland
$75 +$100 +4,697 New
Bank of America
4
Bank of America
North Carolina
$4 +$6 +274 New
Morgan Stanley
5
Morgan Stanley
New York
$3 -$3 -162 -50%

ARTLW Hedge Fund Activity: Q1 2024 in Review

5 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q1 2024, worth a combined $748 — down 55% from $1.66K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ARTLW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $100. The largest seller was Morgan Stanley, cutting an estimated $3.

  • 5 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q1 2024, up from 3 in Q4 2023.
  • Funds reported $748 of Artelo Biosciences, Inc. Warrant stock for Q1 2024, down 55% quarter-over-quarter.
  • 2 funds opened new Artelo Biosciences, Inc. Warrant positions in Q1 2024 and 0 closed out, a net change of +2 holders.
  • The largest Artelo Biosciences, Inc. Warrant buyer in Q1 2024 was UBS Group, an estimated $100 added.
  • The largest Artelo Biosciences, Inc. Warrant seller in Q1 2024 was Morgan Stanley, an estimated $3 sold.

Based on aggregated 13F filings for Q1 2024.